Healthtech Solutions (OTC: HLTT), an innovative portfolio-model life sciences company focused on building impactful solutions for patients and the healthcare system through its subsidiary companies ranging in stage from preclinical to commercial growth, has named finance and biotech veteran Paul Mann to its board of directors. Mann has worked for two decades in the financial and biotechnology industries, including serving as chair of Varian Biopharmaceuticals an emerging biopharmaceutical company. HLTT recently acquired Varian as part of its focus on the development of novel, targeted oncology therapies with transformational potential for cancer patients. Most recently, Mann has been a consultant and analyst for DSAM Partners, where he provided invaluable investment advice relating to the healthcare industry. In addition, Mann has served as CFO at PolarityTE Inc., a biotechnology and regenerative biomaterials company, and a healthcare portfolio manager at Highbridge Capital Management. He has also held a variety of positions at Soros Fund Management, UBS Investment Group, Morgan Stanley and Deutsche Bank, as well as being a scientist at Procter and Gamble, where he was identified as an inventor on patents for skin-care compounds and technologies. In the announcement, Mann stated that he believed HLTT’s portfolio business model leverages his unique intrinsic strengths and experience, and can provide significant value to its subsidiary companies well beyond what’s possible in traditional investment approaches. “Paul’s addition to the board of directors will be invaluable as we execute on our vision to build the next portfolio-model life sciences company,” said Healthtech CEO Ned Swanson, MD, in the press release. “Not only is his background in the financial and biotechnology industries directly applicable to our mission, but his perspective as chairman of VarianBio will inform the leadership of Healthtech how to continuously improve our model.”
To view the full press release, visit https://ibn.fm/nhcp9
About Healthtech Solutions Inc.
Healthtech Solutions is an innovative portfolio-model life sciences company focused on building impactful solutions for patients and the healthcare system through its subsidiary companies ranging in stage from preclinical to commercial growth. Healthtech is driven by innovation and people. At the core, the company philosophy is that highly motivated people with ambitious goals can achieve breakthroughs with the right organizational support. By identifying and building visionary teams within an ecosystem that fuels their strengths, the company believes that it can collectively accelerate the next wave of advancements in healthcare. From HLTT’s perspective, breakthroughs often occur at the intersection of multiple approaches, so the company is agnostic to the solution — therapeutics, devices, diagnostics, digital technology or a combination. In fact, the company hypothesizes that some of the most promising breakthroughs will occur at the interface of these traditional silos, which has already begun to occur. Healthcare, illness and injury are multifactorial, and Healthtech believes the solutions often need to be multipronged to succeed. For more information, visit the company’s website at www.HealthTech-Solutions.com
NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://ibn.fm/HLTT
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.